Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Feldmann

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Journal of Experimental & Clinical Cancer Research : CR|May 20, 2026
Dual CAR-NK cells targeting PD-L1 and ErbB2 (HER2) exhibit cooperative CAR signaling and counteract solid tumor heterogeneityKristin Freudenberg-Jahn, Idan Ben-Horin, Nivedha Murali Shankar, et al.
Journal of Translational Medicine|December 17, 2025
Automated GMP-compatible production of universal CAR Tregs for organ-targeted tolerance inductionKavitha Lakshmi, Alexandra von Jutrzenka-Trzebiatowski, Liliana Loureiro, et al.
Frontiers in Immunology|June 29, 2023
A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cellsAlexandra Kegler, Laura Drewitz, Claudia Arndt, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Journal of Experimental & Clinical Cancer Research : CR|May 20, 2026
Dual CAR-NK cells targeting PD-L1 and ErbB2 (HER2) exhibit cooperative CAR signaling and counteract solid tumor heterogeneityKristin Freudenberg-Jahn, Idan Ben-Horin, Nivedha Murali Shankar, et al.
Journal of Translational Medicine|December 17, 2025
Automated GMP-compatible production of universal CAR Tregs for organ-targeted tolerance inductionKavitha Lakshmi, Alexandra von Jutrzenka-Trzebiatowski, Liliana Loureiro, et al.
Frontiers in Immunology|June 29, 2023
A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cellsAlexandra Kegler, Laura Drewitz, Claudia Arndt, et al.
Pageof 9